Novel 1,1,3-trioxo-2H, 4H-thieno[3,4-e] [1,2,4]thiadiazine derivatives as non-nucleoside reverse transcriptase inhibitors that inhibit human immunodeficiency virus type 1 replicationARRANZ, E; DIAZ, J. A; INGATE, S. T et al.Journal of medicinal chemistry (Print). 1998, Vol 41, Num 21, pp 4109-4117, issn 0022-2623Article

Synthesis of carbon-14 and stable isotope labelled NN414: a potent potassium channel openerJOHANSEN, Steen K; KRISTENSEN, Jesper B; MÜLLER, Lars K et al.Journal of labelled compounds & radiopharmaceuticals. 2004, Vol 47, Num 2, pp 127-138, issn 0362-4803, 12 p.Article

Ring-Fused Thiadiazines as Core Structures for the Development of Potent AMPA Receptor PotentiatorsPIROTTE, B; FRANCOTTE, P; GOFFIN, E et al.Current medicinal chemistry. 2010, Vol 17, Num 30, pp 3575-3582, issn 0929-8673, 8 p.Article

New 3-alkylamino-4H-thieno-1,2,4-thiadiazine 1,1-dioxide derivatives activate ATP-sensitive potassium channels of pancreatic beta cellsNIELSEN, Flemming E; EBDRUP, Søren; WAHL, Philip et al.Journal of medicinal chemistry (Print). 2006, Vol 49, Num 14, pp 4127-4139, issn 0022-2623, 13 p.Article

Inhibition of insulin secretion as a new drug target in the treatment of metabolic disordersBONDO HANSEN, J; ARKHAMMAR, Per O. G; BODVARSDOTTIR, Thora B et al.Current medicinal chemistry. 2004, Vol 11, Num 12, pp 1595-1615, issn 0929-8673, 21 p.Article

Synthesis and anti-HIV activity of 1,1,3-trioxo-2H, 4H-thieno[3,4-e][1,2,4]thiadiazines (TTDS) : A new family of HIV-1 specific non-nucleoside reverse transcriptase inhibitorsARRANZ, M. E; DIAZ, J. A; INGATE, S. T et al.Bioorganic & medicinal chemistry. 1999, Vol 7, Num 12, pp 2811-2822, issn 0968-0896Article

Synthesis and anti-HIV evaluation of novel 1,3-disubstituted thieno[3,2-c][1,2,6]thiadiazin-4(3Η)-one 2,2-dioxides(TTDDs)YONGQIANG LIN; XINYONG LIU; RENZHANG YAN et al.Bioorganic & medicinal chemistry. 2008, Vol 16, Num 1, pp 157-163, issn 0968-0896, 7 p.Article

Good oral absorption prediction on non-nucleoside benzothiadiazine dioxide human cytomegalovirus inhibitors using combined chromatographic and neuronal network techniquesGIL, Carmen; DORRONSORO, Isabel; CASTRO, Ana et al.Bioorganic & medicinal chemistry letters (Print). 2005, Vol 15, Num 7, pp 1919-1921, issn 0960-894X, 3 p.Article

6-Chloro-3-alkylamino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide derivatives potently and selectively activate atp sensitive potassium channels of pancreatic β-cellsNIELSEN, Flemming E; BODVARSDOTTIR, Thora B; JUNAGER, Finn et al.Journal of medicinal chemistry (Print). 2002, Vol 45, Num 19, pp 4171-4187, issn 0022-2623Article

Towards selective Kir6.2/SUR1 potassium channel openers, medicinal chemistry and therapeutic perspectivesHANSEN, John Bondo.Current medicinal chemistry. 2006, Vol 13, Num 4, pp 361-376, issn 0929-8673, 16 p.Article

Synthesis and pharmacological evaluation of 2,3-dihydro-3-oxo-4H-thieno[3,4-e][1,2,4]thiadiazine 1,1-dioxides as voltage-dependent calcium channel blockersARRANZ, E; DIAZ, J. A; VEGA, S et al.European journal of medicinal chemistry. 2000, Vol 35, Num 7-8, pp 751-759, issn 0223-5234Article

Design and synthesis of some new thiophene, thienopyrimidine and thienothiadiazine derivatives of antipyrine as potential antimicrobial agentsALY, Hala M; SALEH, Nashwa M; ELHADY, Heba A et al.European journal of medicinal chemistry. 2011, Vol 46, Num 9, pp 4566-4572, issn 0223-5234, 7 p.Article

Recent Advances in Antiviral Activity of Benzo/Heterothiadiazine Dioxide DerivativesPENG ZHAN; XINYONG LIU; DE CLERCQ, Erik et al.Current medicinal chemistry. 2008, Vol 15, Num 15, pp 1529-1540, issn 0929-8673, 12 p.Article

Thienothiadiazine 2,2-dioxide acyclonucleosides : synthesis and antiviral activityMARTINEZ, A; ESTEBAN, A; CASTRO, A et al.Antiviral chemistry & chemotherapy. 2000, Vol 11, Num 3, pp 221-230, issn 0956-3202Article